Dallas, Texas (TX) Biological Research Companies

Featured companies
Chemsampco Inc
1880 Ryan Road
Dallas TX 75220
(609) 656-2440
Covance Inc
1341 West Mcknbrd Lane 400w
Dallas TX 75247
(214) 920-9053
Cytomedix Inc
7071b Twin Hills Avenue
Dallas TX 75231
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Dara Aisner
7640 West Greenway Boulevard 4k
Dallas TX 75209
Emanuel Calenoff
7030 Lattimore Drive
Dallas TX 75252
(510) 682-6013
John W Fondon Iii
5323 Harry Hines Boulevard
Dallas TX 75390
(214) 648-8003
Orisyn Research
5930 Royal Lane # 333
Dallas TX 75230
Strike Bio Inc
1700 Pacific Avenue # 1100
Dallas TX 75201
(214) 220-4304
Asnlife LLC
828 East Irving Boulevard
Irving TX 75060
(469) 442-6818
Zyx Biotech Company
1452 Halsey Way # 100
Carrollton TX 75007
(972) 820-7820
Helix Material Solutions Inc
430 Buckingham Road # 1633
Richardson TX 75081
(214) 738-7806

Helix Material Solutions Inc is a privately held company in Richardson, TX and is a Single Location business.
Reata Pharmaceuticals Inc
1302 E Collins Boulevard
Richardson TX 750812403
(214) 576-9804
Whereorg has 12 results under Biological Research Companies in Dallas.

Narrow down the browsing criteria below to see more companies.

Select a location for category Biological Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020